Cargando…

Interleukin33 deficiency causes tau abnormality and neurodegeneration with Alzheimer-like symptoms in aged mice

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Carlock, C, Wu, J, Shim, J, Moreno-Gonzalez, I, Pitcher, M R, Hicks, J, Suzuki, A, Iwata, J, Quevado, J, Lou, Y
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611742/ https://www.ncbi.nlm.nih.gov/pubmed/28763061 http://dx.doi.org/10.1038/tp.2017.176

Ejemplares similares

Interleukin33 deficiency causes tau abnormality and neurodegeneration with Alzheimer-like symptoms in aged mice
por: Carlock, C, et al.
Publicado: (2017)

Requirement of brain interleukin33 for aquaporin4 expression in astrocytes and glymphatic drainage of abnormal tau
por: Wu, Jean, et al.
Publicado: (2021)

Parkinson’s disease managing reversible neurodegeneration [Corrigendum]
Publicado: (2016)

Implication of tau propagation on neurodegeneration in Alzheimer’s disease
por: Lamontagne-Kam, Daniel, et al.
Publicado: (2023)

Corrigendum to ‘A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19’
por: McElvaney, Oliver J, et al.
Publicado: (2020)

Mechanism of neurodegeneration through tau and therapy for Alzheimer's disease
por: Takashima, Akihiko
Publicado: (2016)

Plasma phosphorylated tau181 and neurodegeneration in Alzheimer’s disease
por: Hansson, Oskar, et al.
Publicado: (2020)

Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease
por: Iaccarino, Leonardo, et al.
Publicado: (2017)

Neurodegeneration Caused by S1P-Lyase Deficiency Involves Calcium-Dependent Tau Pathology and Abnormal Histone Acetylation
por: Alam, Shah, et al.
Publicado: (2020)

Corrigendum to ‘Tiered restrictions for COVID-19 in England: Knowledge, motivation and self-reported behaviour’ [Public Health 204 (2022) 33–39]
por: Smith, L.E., et al.
Publicado: (2022)

Corrigendum to abnormalities in personal space and parietal–frontal function in schizophrenia
por: Holt, Daphne J., et al.
Publicado: (2016)

Corrigendum to “Deletion of Crry, the murine ortholog of the sporadic Alzheimer's disease risk gene CR1, impacts tau phosphorylation and brain CFH” [Neurosci. Lett. 533 (2013) 96–99]
por: Killick, R., et al.
Publicado: (2013)

Abnormal expression and function of the E-cadherin–catenin complex in gastric carcinoma cell lines
por: Jawhari, A U, et al.
Publicado: (2014)

Long non‐coding RNA MALAT1 regulates retinal neurodegeneration through CREB signaling
por: Yao, Jin, et al.
Publicado: (2016)

Advances in the Pathogenesis of Alzheimer’s Disease: Focusing on Tau-Mediated Neurodegeneration
por: Duan, Yale, et al.
Publicado: (2012)

The Role of Mitochondrial Impairment in Alzheimer´s Disease Neurodegeneration: The Tau Connection
por: Quntanilla, Rodrigo A., et al.
Publicado: (2020)

Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer's disease
por: Jiao, S-S, et al.
Publicado: (2016)

The Many Faces of Post-Ischemic Tau Protein in Brain Neurodegeneration of the Alzheimer’s Disease Type
por: Pluta, Ryszard, et al.
Publicado: (2021)

Neuroprotective Effects of Melatonin and Celecoxib against Ethanol-Induced Neurodegeneration: A Computational and Pharmacological Approach [Corrigendum]
Publicado: (2023)

Loss of Axonal Mitochondria Promotes Tau-Mediated Neurodegeneration and Alzheimer's Disease–Related Tau Phosphorylation Via PAR-1
por: Iijima-Ando, Kanae, et al.
Publicado: (2012)

Corrigendum to “Effect of Short-Term Stimulation with Interleukin-1β and Differentiation Medium on Human Mesenchymal Stromal Cell Paracrine Activity in Coculture with Osteoblasts”
por: Voss, Jan O., et al.
Publicado: (2016)

Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease
por: Moscoso, Alexis, et al.
Publicado: (2021)

Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury
por: Martens, Lauren Herl, et al.
Publicado: (2022)

Tau-mediated Neurodegeneration and Potential Implications in Diagnosis and Treatment of Alzheimer's Disease
por: Wu, Xi-Lin, et al.
Publicado: (2017)

Effects of Toll-like receptor antagonist 4,5-dihydro-3-phenyl-5-isoxasole acetic acid on the progression of kidney disease in mice on a high-fat diet [Volume 33, Issue 1, March 2014, Pages 33–44]
por: Min, Hye Sook, et al.
Publicado: (2015)

Corrigendum to “MIG (CXCL9) is a more sensitive measure than IFN-γ of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines” [J. Immunol. Methods 340 (2009) 33–41]
por: Berthoud, Tamara K., et al.
Publicado: (2011)

The role of tau in neurodegeneration
por: Gendron, Tania F, et al.
Publicado: (2009)

Tramiprosate, a drug of potential interest for the treatment of Alzheimer's disease, promotes an abnormal aggregation of tau
por: Santa-Maria, Ismael, et al.
Publicado: (2007)

Alpha-synuclein and tau: teammates in neurodegeneration?
por: Moussaud, Simon, et al.
Publicado: (2014)

Corrigendum to “Controlled Release of Interleukin-1 Receptor Antagonist from Hyaluronic Acid-Chitosan Microspheres Attenuates Interleukin-1β-Induced Inflammation and Apoptosis in Chondrocytes”
por: Qiu, Bo, et al.
Publicado: (2020)

IL-33 deficiency causes persistent inflammation and severe neurodegeneration in retinal detachment
por: Augustine, Josy, et al.
Publicado: (2019)

Corrigendum to “Interleukin 18 and coronary heart disease: Prospective study and systematic review” [Atherosclerosis 217 (2011) 227–233]
por: Jefferis, Barbara J.M.H., et al.
Publicado: (2011)

Corrigendum to “Abnormal brain connectivity in first-episode psychosis: A diffusion MRI tractography study of the corpus callosum” [NeuroImage 35 (2007) 458–466]
por: Price, Gary, et al.
Publicado: (2007)

Tau-Mediated Disruption of the Spliceosome Triggers Cryptic RNA Splicing and Neurodegeneration in Alzheimer’s Disease
por: Hsieh, Yi-Chen, et al.
Publicado: (2019)

Antisense-mediated Exon Skipping Decreases Tau Protein Expression: A Potential Therapy for Tauopathies
Publicado: (2014)

Corrigendum: Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression
Publicado: (2021)

The effect of feeding adequate or deficient vitamin B(6) or folic acid to breeders on methionine metabolism in 18-day-old chick embryos
por: Lu, J., et al.
Publicado: (2021)

Corrigendum to “Role of Interleukin-18 in Modulation of Oral Carcinoma Cell Proliferation”
por: Inflammation, Mediators of
Publicado: (2018)

Contribution of Tau Pathology to Mitochondrial Impairment in Neurodegeneration
por: Pérez, María J., et al.
Publicado: (2018)

Participation of Amyloid and Tau Protein in Post-Ischemic Neurodegeneration of the Hippocampus of a Nature Identical to Alzheimer’s Disease
por: Pluta, Ryszard, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dp7ntikj5q2594qdrg82uu06dj